It is a pharma private limited company based in Newtown, West Bengal, India, established in 2022.
2022 | Newtown, West Bengal, India | ActiveSilexx Pharmaceuticals Private Limited, a active private limited company, was established on 19 September 2022 in Newtown, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24230WB2022PTC257271. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Indrajeet Kumar (Director), Runi Kumari (Director). It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Sunil Kumar,Omkrishna,Co-Opt.Housing Soc.Ltd,Plot-Dc127,Flatno-1Astreetno-310, Newtown, West Bengal, 700156.
U24230WB2022PTC257271
257271
19 September 2022
₹1.50 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Silexx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Indrajeet Kumar | Director | 19 Sep 2022 | Current |
| Runi Kumari | Director | 19 Sep 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Silexx Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Silexx Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2023 | State Bank Of India | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Silexx Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Silexx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silexx Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Silexx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Silexx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 3.00 M with Charge ID 100713710 was registered on 27 Mar 2023. was documented.
The activity Indrajeet Kumar was appointed as a Director was appointed as a Director on 19 Sep 2022 & has been associated with this company since 3 years 2 months . was completed.
Progress on Runi Kumari was appointed as a Director was appointed as a Director on 19 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
The activity Silexx Pharmaceuticals Private Limited was registered on 19 Sep 2022 with Roc Kolkata & aged 3 years 2 months as per MCA records. was completed.
The CIN of Silexx Pharmaceuticals Private Limited is U24230WB2022PTC257271.
Silexx Pharmaceuticals Private Limited is headquartered at C/O Sunil Kumar,Omkrishna,Co-Opt.Housing Soc.Ltd,Plot-Dc127,Flatno-1Astreetno-310, Newtown, West Bengal, 700156.
Silexx Pharmaceuticals Private Limited was incorporated on 19 September 2022.
The current directors of Silexx Pharmaceuticals Private Limited are
The primary industry of Silexx Pharmaceuticals Private Limited is Hospital And Medical Care.
Silexx Pharmaceuticals Private Limited is unlisted.
The authorized capital of Silexx Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Silexx Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX